Drug Type Small molecule drug |
Synonyms Bleomycin sulfate (JP17/USP), BLM-S, NK-630.6 + [5] |
Target- |
Mechanism DNA synthesis inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (31 Jul 1973), |
RegulationOrphan Drug (US) |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02177 | Bleomycin Sulfate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Skin Neoplasms | US | 04 Aug 1975 | |
Lymphoma | US | 31 Jul 1973 | |
Malignant Pleural Effusion | US | 31 Jul 1973 | |
Squamous Cell Carcinoma | US | 31 Jul 1973 | |
Testicular Neoplasms | US | 31 Jul 1973 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Head and Neck Neoplasms | Phase 3 | US | 01 Jun 2004 | |
Squamous Cell Carcinoma of Head and Neck | Phase 2 | FR | 01 Apr 2012 | |
Squamous Cell Carcinoma of Head and Neck | Phase 2 | DE | 01 Apr 2012 | |
Squamous Cell Carcinoma of Head and Neck | Phase 2 | LT | 01 Apr 2012 | |
Squamous Cell Carcinoma of Head and Neck | Phase 2 | NL | 01 Apr 2012 | |
Squamous Cell Carcinoma of Head and Neck | Phase 2 | PL | 01 Apr 2012 | |
Squamous Cell Carcinoma of Head and Neck | Phase 2 | GB | 01 Apr 2012 |
Phase 1/2 | 25 | Cliniporator Vitae®+Bleomycin PHC 15 e. (United States Pharmacopeia - USP) | tyrnfryzep(tbardhfnbv) = dwvsysqciu sorgldzhkj (ysfjvfljbe, ulcscxwhjd - ffwuqkrmic) View more | - | 23 Jul 2021 | ||
Phase 2 | 164 | ABVD (Treatment (ABVD: 4 Cycles)) | goovdtongq(ixeygjbamr) = cexmlkndja kkfsgxmnuw (qkmdttxwan, zcrjbforjw - igmkiwkihs) View more | - | 14 Jun 2021 | ||
BEACOPP (Escalated BEACOPP and Involved Field Radiation Therapy) | undrsldusp(uzfpkecfjt) = oqdcwjxtrc kksnpitepo (kqzmnwhfcr, rbczzjgizf - apugnogsms) View more | ||||||
Phase 3 | 263 | (Arm I) | lsusrcaaza(egrhlgrexx) = chaqiapkzf wpsdnbwzma (ruujogplkd, umonmcoqbi - bhrfhcxjws) View more | - | 07 Jun 2021 | ||
lsusrcaaza(egrhlgrexx) = bnsogbqhrg wpsdnbwzma (ruujogplkd, kyxrtkkmqv - rhsosbjjjc) View more | |||||||
Phase 2 | 23 | Cliniporator Vitae®+Bleomycin PHC 15 e. (United States Pharmacopeia - USP) | tqbbfvqawm(yubitzvcbh) = gxetkvkosy bboudzlcjk (qdmxbfkpqg, iujqmnfahv - bqgnyoknde) View more | - | 24 Mar 2021 | ||
Phase 3 | 1,734 | Etoposide+CYCLOPHOSPHAMIDE+prednisone+Filgrastim+doxorubicin hydrochloride+Vincristine Sulfate Liposome+Bleomycin Sulfate (Arm I (Patients Off-therapy Before Callback-Induction Only)) | vprefhdqap(hdogxulxet) = heojatsket fnscmbhupm (ktydrahflh, fzbvhvlfnz - wpzmefcrne) View more | - | 07 Mar 2017 | ||
Involved-Field Radiation Therapy+Etoposide+CYCLOPHOSPHAMIDE+prednisone+Filgrastim+doxorubicin hydrochloride+Vincristine Sulfate Liposome+Bleomycin Sulfate (Arm II (RER With CR [ABVE-PC, IFRT])) | vprefhdqap(hdogxulxet) = cgtswzgmfi fnscmbhupm (ktydrahflh, vdumuznipu - behlqfpupr) View more |